Baidu
map

医药电商发展的出路

2017-08-22 医药史立臣 MedSci原创

其实,我思考医药电商发展的问题已经很长时间了, 但和很多做医药电商的企业朋友或者计划进入医药电商的朋友的境况一样,没找到很好的盈利构架。

其实,我思考医药电商发展的问题已经很长时间了。但和很多做医药电商的企业朋友或者计划进入医药电商的朋友的境况一样,没找到很好的盈利构架。明知道“以送药”为核心模式的现行医药电商模式不会成功,但怎样找到医药电商的盈利架构是颇费脑子的事情。笔者把近期思考的内容梳理了一下,供大家参考。1.医药电商市场首先是多边市场实际上,我们应该理清一点!医药电商市场首先是多边市场。这个多边市场包括平台、制药企业、配送方、药店、消费者、医院、政府、医保。不管是药企的医药电商平台还是纯粹的医药电商平台,在构建自己的医药电商体系时,都会面临多边市场的需求。医药电商平台构建的其实是医药健康生态圈,这种生态圈的需求是多方面的,而不是单一的配送药服务。2.消费者用药需求是一个伪需求很多医药电商平台动辄就将给消费者送药到家作为主要的平台构建核心,但大量的以配送药品为主体经营模式的电商平台都遇到了发展困境,一些平台甚至面临倒闭。前面提到过,目前全国有40多万家药店,医疗卫生机构数达98.7万个。可见,消费者获得药品的途径非常多,而不是很难获得药品,比如任何社区半径0.5公里范围内,都有少则2家、多则七八家的药店,还有很多门

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1647585, encodeId=899a164e58580, content=<a href='/topic/show?id=ad5f3536193' target=_blank style='color:#2F92EE;'>#医药电商#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35361, encryptionId=ad5f3536193, topicName=医药电商)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ca223453562, createdName=liuyong2988, createdTime=Thu Dec 28 18:18:00 CST 2017, time=2017-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236615, encodeId=982c2366153e, content=谢谢分享谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Thu Aug 24 09:28:39 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409028, encodeId=79c41409028e1, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Aug 24 06:18:00 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236218, encodeId=dc382362182e, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Wed Aug 23 06:51:21 CST 2017, time=2017-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236070, encodeId=9d6b2360e0b4, content=学习了受益匪浅., beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue Aug 22 17:39:22 CST 2017, time=2017-08-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1647585, encodeId=899a164e58580, content=<a href='/topic/show?id=ad5f3536193' target=_blank style='color:#2F92EE;'>#医药电商#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35361, encryptionId=ad5f3536193, topicName=医药电商)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ca223453562, createdName=liuyong2988, createdTime=Thu Dec 28 18:18:00 CST 2017, time=2017-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236615, encodeId=982c2366153e, content=谢谢分享谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Thu Aug 24 09:28:39 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409028, encodeId=79c41409028e1, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Aug 24 06:18:00 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236218, encodeId=dc382362182e, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Wed Aug 23 06:51:21 CST 2017, time=2017-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236070, encodeId=9d6b2360e0b4, content=学习了受益匪浅., beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue Aug 22 17:39:22 CST 2017, time=2017-08-22, status=1, ipAttribution=)]
    2017-08-24 明天会更好!

    谢谢分享谢谢分享!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1647585, encodeId=899a164e58580, content=<a href='/topic/show?id=ad5f3536193' target=_blank style='color:#2F92EE;'>#医药电商#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35361, encryptionId=ad5f3536193, topicName=医药电商)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ca223453562, createdName=liuyong2988, createdTime=Thu Dec 28 18:18:00 CST 2017, time=2017-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236615, encodeId=982c2366153e, content=谢谢分享谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Thu Aug 24 09:28:39 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409028, encodeId=79c41409028e1, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Aug 24 06:18:00 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236218, encodeId=dc382362182e, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Wed Aug 23 06:51:21 CST 2017, time=2017-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236070, encodeId=9d6b2360e0b4, content=学习了受益匪浅., beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue Aug 22 17:39:22 CST 2017, time=2017-08-22, status=1, ipAttribution=)]
    2017-08-24 cathymary
  4. [GetPortalCommentsPageByObjectIdResponse(id=1647585, encodeId=899a164e58580, content=<a href='/topic/show?id=ad5f3536193' target=_blank style='color:#2F92EE;'>#医药电商#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35361, encryptionId=ad5f3536193, topicName=医药电商)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ca223453562, createdName=liuyong2988, createdTime=Thu Dec 28 18:18:00 CST 2017, time=2017-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236615, encodeId=982c2366153e, content=谢谢分享谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Thu Aug 24 09:28:39 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409028, encodeId=79c41409028e1, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Aug 24 06:18:00 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236218, encodeId=dc382362182e, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Wed Aug 23 06:51:21 CST 2017, time=2017-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236070, encodeId=9d6b2360e0b4, content=学习了受益匪浅., beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue Aug 22 17:39:22 CST 2017, time=2017-08-22, status=1, ipAttribution=)]
    2017-08-23 189****7206

    学习了受益匪浅

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1647585, encodeId=899a164e58580, content=<a href='/topic/show?id=ad5f3536193' target=_blank style='color:#2F92EE;'>#医药电商#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35361, encryptionId=ad5f3536193, topicName=医药电商)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ca223453562, createdName=liuyong2988, createdTime=Thu Dec 28 18:18:00 CST 2017, time=2017-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236615, encodeId=982c2366153e, content=谢谢分享谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Thu Aug 24 09:28:39 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409028, encodeId=79c41409028e1, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Aug 24 06:18:00 CST 2017, time=2017-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236218, encodeId=dc382362182e, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Wed Aug 23 06:51:21 CST 2017, time=2017-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=236070, encodeId=9d6b2360e0b4, content=学习了受益匪浅., beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue Aug 22 17:39:22 CST 2017, time=2017-08-22, status=1, ipAttribution=)]
    2017-08-22 131****1460

    学习了受益匪浅.

    0

相关资讯

避免原营销体系惯性延续的解决途径

想建立有效率的事业部就需要制药企业有产品战略。在产品战略基础上,我们就能知道某一产品群的市场宽度、市场容量和市场竞争状态,再根据制药企业的发展目标判断是否需要构建事业部。

2017医药营销会呈现哪些态势?

笔者认为,2017年医药行业的营销状况会呈现以下态势: 1. 控销模式将面临巨大的政策压力 控销模式在2017年的94号文件、“两票制”和营改增政策下,面临崩溃的风险。 以控销为主要模式的制药企业或商业企业,面对通过大包模式形成的庞大自然人群体,由于无法在新政策环境下给予其合规的药品经营身份,这些自然人面临被其他药企收编,或者放弃医药行业转行。 而“两票制”也让原来自然人通过挂靠、走票等模式成为

重塑药品流通秩序,推进药品流通体制改革

“打破医药产品市场分割、地方保护,推动药品流通企业跨地区、跨所有制兼并重组,培育大型现代药品流通骨干企业。” 地方保护和多年形成的积习、陋习,一句话能解决吗?这一点如果没有具体实施细则,很难啊!跨区域经营,是降低渠道费用的一个关键点。

医疗器械行业洗牌加速

根据中商产业研究院大数据库显示:截至2016年4 月30日,我国医疗行业上市企业2015年营收达258.44 亿元,通过对23家医疗器械企业营业收人和净利润排名,除了九安医疗外,基本都盈利。

大量药企艰难度日,“剩者为王”?

这段时间受邀参加了两个医药行业高层沙龙活动。 参加沙龙的基本上是药企的董事长、总经理。 以前笔者史立臣参加类似的医药行业高管沙龙是大家讨论如何做的更好,如何发展企业,如何彼此对接资源,如何相互学习有效管理。

提高药品质量疗效,促进医药产业结构调整

从事医药经营管理这么多年,第一次见到国家如此精准、如此全面、如此重手、如此细致地发布影响医药行业整个经营的重大政策。

Baidu
map
Baidu
map
Baidu
map